Outcome of Bacterial Meningitis in Children age 1 Month – 12 Years in a Public st SectorHospital Treated with 1 line Antibiotics
DOI:
https://doi.org/10.51273/esc22.251841Keywords:
Acute bacterial meningitis, first line antibiotics, second line antibiotics, antibiotic resistanceAbstract
Objective: To determine the effectiveness of using first line antibiotics for the treatment of acute bacterial meningitis in children admitted in a public sector hospital and assessing its outcome with the help of data by need for using second line antibiotics therapy and length of stay in hospital.
Method: This Crosssectional study was conducted at department of Pediatrics, Pakistan Institute of Medical Sciences, Islamabad over a period of 6 months from January 2019 to July 2019. All children between the age of 1 month – 12 years, of both genders admitted in pediatric ward with acute bacterial meningitis, based on clinical features plus CSF findings, were enrolled in the study. These children were started with first line antibiotic therapy after admission in ward which included ceftriaxone alone or a combination of ampicillin and cefotaxime or cefotaxime plus amikacin depending on age specific recommendations for that age group. All children were closely observed in ward for improvement or deterioration of symptoms. If there was deterioration of symptoms, then second line antibiotics were started which in our case was vancomycin combined with ceftriaxone or meropenem combined with vancomycin. Duration of hospital stay was also noted. Data was analyzed by SPSS version 22.
Results: A total of 51 patients were enrolled in the study. Mean age of children in the study was 3.23 ± 3.3 years. There were 33(65.1%) males and 18(34.9%) females. Only 30(58.6%) children were completely vaccinated, rest were either partially vaccinated or not vaccinated at all. ]In the first line antibiotics course, ceftriaxone was the most common antibiotic, which was prescribed to 32(61.3%) children, followed by a combination of cefotaxime with amikacin 13(23.7%) and ampicillin plus cefotaximeto 6(4.3%). Second line therapy was needed in only15(29%) children. The commonly prescribed was a combination of vancomycin and meropenem. The total duration of stay in hospital was for 10-14 days.
Conclusion: Our study concluded that first line antibiotic therapy is still an effective treatment for acute bacterial meningitis. So, in the wake of emerging antibiotic resistance, irrational use of antibiotics should be avoided.
References
Fayyaz J, Rehman A, Hamid A, Khursheed M, Zia N, Feroze A. Age related clinical manifestation of acute bacterial meningitis in children. Journal of Pakistan Medical Association. 2014;64(3):296.
Ali Z, Yousaf K, Razzaq S, Farooq U, Gulbaqir HM. Different Incidences of Acute Bacterial Meningitis in Children of Central Punjab in Pakistan. ARCHIVOS DE MEDICINA. 2017;8(S4):231.
Zainel A, Mitchell H, Sadarangani M. Bacterial menin- gitis in children: neurological complications, associated risk factors, and prevention. Microorganisms. 2021 Mar 5;9(3):535.
Runde TJ, Anjum F, Hafner JW. Bacterial meningitis. InStatPearls [Internet] 2021 Dec 8. StatPearls Publishing.
Tacon CL, Flower O. Diagnosis and management of bacterial meningitis in the paediatric population: a review. Emergency medicine international. 2012 Sep 20; 2012.
Swanson D. Meningitis.Pediatrics in review. 2015 Dec 1;36(12):514-26.
Slack M, Esposito S, Haas H, Mihalyi A, Nissen M, Mukherjee P, Harrington L. Haemophilusinfluenzae
type b disease in the era of conjugate vaccines: Critical factors for successful eradication. Expert Review of Vaccines. 2020 Oct 2;19(10):903-17.
Nhantumbo AA, Cantarelli VV, Caireão J, Munguambe AM, Comé CE, Pinto GD, Zimba TF, Mandomando I,
Semá CB, Dias C, Moraes MO. Frequency of pathogenic paediatric bacterial meningitis in Mozambique: the critical role of multiplex real-time polymerase chain reaction to estimate the burden of disease. PloS one. 2015 Sep 22;10(9):e0138249.
Farajzadeh Sheikh A, Rahimi R, Meghdadi H, Alami A, Saki M. Multiplex polymerase chain reaction detection of Streptococcus pneumoniae and Haemophilus in- fluenzae and their antibiotic resistance in patients with community-acquired pneumonia from southwest Iran. BMC microbiology. 2021 Dec;21(1):1-8.
Pick AM, Sweet DC, Begley KJ. A review of pediatric bacterial meningitis. US Pharm. 2016 May 1;41(5): 41-5.
Li B, Webster TJ. Bacteria antibiotic resistance: New challenges and opportunities for implant‐associated
orthopedic infections. Journal of Orthopaedic Research®. 2018 Jan;36(1):22-32.
Saleem Z, Saeed H, Hassali MA, Godman B, Asif U, Yousaf M, Ahmed Z, Riaz H, Raza SA. Pattern of in-
appropriate antibiotic use among hospitalized patients in Pakistan: a longitudinal surveillance and implications.
Antimicrobial Resistance & Infection Control. 2019 Dec;8(1):1-7.
Gandra S, Alvarez-Uria G, Turner P, Joshi J, Limmathurotsakul D, van Doorn HR. Antimicrobial resistance surveillance in low-and middle-income countries: progress and challenges in eight South Asian and South- east Asian countries. Clinical Microbiology Reviews. 2020 Jun 10;33(3):e00048-19.
Iftikhar S, Sarwar MR, Saqib A, Sarfraz M. Antibiotic prescribing practices and errors among hospitalized pediatric patients suffering from acute respiratory tract infections: a multicenter, cross-sectional study in Pakistan. Medicina. 2019 Feb;55(2):44.
Mubarak N, Khan AS, Zahid T, Aziz MM, Khan R, Mahmood K, Saif-ur-Rehman N, Zin CS. Assessment of Adherence to the Core Elements of Hospital Antibiotic Stewardship Programs: A Survey of the Tertiary Care Hospitals in Punjab, Pakistan. Antibiotics. 2021 Aug; 10(8): 906.
Ali SA, Taj MK, Ali SH. Antimicrobial Resistance Pattern of Bacterial Meningitis Among Patients in Quetta, Pakistan. Infection and Drug Resistance. 2021; 14: 5107.
Umer MF, Zofeen S, Hu W, Qi X, Zhuang G. Spatio- temporal clustering analysis of Expanded Program on
Immunization (EPI) vaccination coverage in Pakistan. Scientific reports. 2020 Jul 3;10(1):1-1.
Nisar MI, Shahid S, Jehan F, Ahmed S, Shakoor S, Kabir F, Hotwani A, Munir S, Khalid F, Muhammad S, Whitney CG.Antimicrobial Resistance in Pneumococcal Carriage Isolates from Children under 2 Years of Age
in Rural Pakistan. Microbiology spectrum. 2021 Nov 9(3):e01019-21
World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed.
Bilal H, Khan MN, Rehman T, Hameed MF, Yang X. Antibiotic resistance in Pakistan: a systematic review of past decade. BMC infectious diseases. 2021 Dec 21(1):1-9.
Beyrouthy R, Barets M, Marion E, Dananché C, Dau- walder O, Robin F, Gauthier L, Jousset A, Dortet L, Guérin F, Bénet T. Novel Enterobacter lineage as leading cause of nosocomial outbreak involving carbapenemase-
producing strains. Emerging infectious diseases. 2018 Aug;24(8):1505.
Davin-Regli A, Lavigne JP, PagèsJM.Enterobacter spp.: update on taxonomy, clinical aspects, and emerging
antimicrobial resistance. Clinical microbiology reviews. 2019 Sep 18;32(4):e00002-19.
Spellberg B, Gilbert DN. The future of antibiotics and resistance: a tribute to a career of leadership by John
Bartlett. Clinical infectious diseases. 2014 Sep 15; 59(suppl_2):S71-5.
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics. 2015 Apr;40(4):277.
Viswanathan VK. Off-label abuse of antibiotics by bacteria. Gut microbes. 2014 Jan 1;5(1):3-4.
